Home
Conditions
Kidney Diseases

Clinical trial condition

Kidney Diseases

Explore clinical trials studying Kidney Diseases. Study availability and eligibility vary by location and protocol.

8,885 public trials 1,418 recruiting studies

Refine in advanced search Browse all conditions

Kidney Diseases trial results

Recruiting

Effect of Empagliflozin on Podocyte Specific Proteins in African American Veterans With NDKD

NCT06110130

Conditions: Chronic Disease, Chronic Kidney Diseases, Disease Attributes, +10 more
Locations: Washington DC Veterans Affairs Medical Center (688) Washington D.C., District of Columbia, United States

View Trial Details

Recruiting

A Study to Evaluate Mosunetuzumab in Participants With Systemic Lupus Erythematosus With or Without Active Lupus Nephritis

NCT07598396

Conditions: Autoimmune Diseases, Connective Tissue Diseases, Female Urogenital Diseases, +13 more
Locations: Clnica SER da Bahia Salvador, Estado de Bahia, Brazil

L2IP ?Instituto de Pesquisas Clínicas Ltda. Brasília, Federal District, Brazil

IPC MT Instituto de Pesquisas Clinicas do Mato Grosso Cuiab, Mato Grosso, Brazil

Complexo Hospitalar de Niteroi Niterói, Rio de Janeiro, Brazil

View all 21 locations

View Trial Details

Recruiting

Identifying Oxytocin Deficiency in Pediatric Patients With Pituitary Disease

NCT07568509

Conditions: Arginine Vasopressin Deficiency, Brain Diseases, Central Nervous System Diseases, +15 more
Locations: Massachusetts General Hospital Boston, Massachusetts, United States

View Trial Details

Recruiting

A Phase 3 Study of Etelcalcetide in Children With Secondary Hyperparathyroidism Receiving Hemodialysis

NCT03969329

Conditions: Chronic Disease, Disease Attributes, Endocrine System Diseases, +14 more
Locations: Universitair Ziekenhuis Gent Ghent, Belgium

Fakultni nemocnice v Motole Prague, Czechia

Hospices Civils de Lyon Hopital Femme Mere Enfant Bron, France

Hopital Armand Trousseau Paris, France

View all 23 locations

View Trial Details

Recruiting

A First-in-Human Study of HH160 in Participants With Advanced or Metastatic Solid Tumors

NCT07623369

Conditions: Adenocarcinoma, Adnexal Diseases, Breast Diseases, +69 more
Locations: Calvary Mater Newcastle Waratah, New South Wales, Australia

Tasman Health Care Southport, Queensland, Australia

Shandong Tumour Hospital Dongyuan Unit Jinan, Shandong, China

View Trial Details

Recruiting

Yttrium-90 (Y90) Radioembolization for the Treatment of Early Stage Renal Cell Carcinoma, The RENEGADE Trial

NCT06432036

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +15 more
Locations: UCLA / Jonsson Comprehensive Cancer Center Los Angeles, California, United States

University of Colorado Anschutz Medical Campus Aurora, Colorado, United States

View Trial Details

Recruiting

EASi-KIDNEY™ (The Studies of Heart & Kidney Protection With BI 690517 in Combination With Empagliflozin)

NCT06531824

Conditions: Chronic Disease, Disease Attributes, Female Urogenital Diseases, +10 more
Locations: Apogee Clinical Research Huntsville, Alabama, United States

Southwest Kidney Institute Surprise, Arizona, United States

National Heart Institute Beverly Hills, California, United States

Florida Kidney Physicians LLC Jacksonville Beach, Florida, United States

View all 515 locations

View Trial Details

Recruiting

Role of Pre-stenting Before Retrograde Intrarenal Surgery With Miniaturized Flexible Ureteroscopes

NCT07773090

Conditions: Calculi, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +11 more
Locations: Department of Urology, Al-Hussein and Sayed Galal University Hospitals, Al-Azhar University Cairo, Egypt

View Trial Details

Recruiting

A Study to Find Out How EMPAgliflozin is Tolerated and if it Helps Children and Adolescents With Chronic KIDNEY Disease (EMPA-KIDNEY® Kids)

NCT07107945

Conditions: Chronic Disease, Chronic Kidney Disease, Disease Attributes, +10 more
Locations: University of Alabama at Birmingham Birmingham, Alabama, United States

Phoenix Children's Hospital Phoenix, Arizona, United States

University of California Los Angeles Los Angeles, California, United States

Stanford University School of Medicine Palo Alto, California, United States

View all 97 locations

View Trial Details

Recruiting

A Study of Sasanlimab, Palbociclib and Axitinib in Metastatic Renal Cell Carcinoma

NCT07123090

Conditions: Adenocarcinoma, Advanced Clear Cell Renal Cell Carcinoma, Carcinoma, +19 more
Locations: Brigham and Women's Hospital Boston, Massachusetts, United States

Dana-Farber Cancer Institute Boston, Massachusetts, United States

View Trial Details

Kidney Diseases

Kidney Diseases trial results

Related conditions